Skip to content
Contact Us
KCAS Blog
Careers
Menu Toggle
Why a Career at KCAS
Roles We Hire
Menu Toggle
Scientist Jobs
Business Jobs
New Grads
How You’ll Benefit
Search for:
Home
ABOUT
Menu Toggle
Why KCAS?
Leadership Team
Quality Assurance
Client Testimonials
SOLUTIONS
Menu Toggle
BIOMARKERS
Menu Toggle
Exploratory
Regulated CTA (Clinical Trial Application)
Non-Reg CTA (Clinical Trial Application)
MOLECULE TYPE
Menu Toggle
Small Molecule
Large Molecule
Cell & Gene Therapy
Other (Mixed-Mode Macro-Molecules)
RESEARCH PHASE
Menu Toggle
Early Research
Discovery
Pre-Clinical
Clinical Development
Manufacturing & Commercialization
Therapeutic Area
Menu Toggle
Autoimmune and Immunological
Cancer/Oncology
Cardiovascular & Metabolic
Gastrointestinal
Neurological Disorders
Ophthalmology
Orphan/Rare Diseases
Respiratory
Renal (kidney)
Infectious Diseases & Vaccines
Platforms
Menu Toggle
ELISA
ELISpot
Flow Cytometry
Hybrid LC-MS/MS
LC-MS/MS
Ligand Binding Assays
Meso Scale Discovery (ECL)
LC-UV/Fluorescence
Luminex
Quantitative PCR (qPCR and ddPCR)
IsoPlexis
News & Events
Menu Toggle
Upcoming Events
News
Resources
Menu Toggle
Compound Classes
Posters & White Papers
Info Sheets
Main Menu
LC-MS/MS
KCAS has established a wide range of assays in various biological matrices.
The methods tabulated below vary from Qualified to Fully Validated Methods.
Assay Search
Paroxetine
Matrix:
Human Plasma
LLOQ:
100
Unit:
pg/mL
Platform:Â
LC-MS/MS
Pentazocine
Matrix:
Human Plasma
LLOQ:
1
Unit:
ng/mL
Platform:Â
LC-MS/MS
Phenylephrine
Matrix:
Human Urine
LLOQ:
5
Unit:
ng/mL
Platform:Â
LC-MS/MS
Phenylephrine
Matrix:
Human Plasma
LLOQ:
0.5
Unit:
ng/mL
Platform:Â
LC-MS/MS
Primidone
Matrix:
Human Plasma
LLOQ:
25
Unit:
ng/mL
Platform:Â
LC-MS/MS
Propafenone / N-Despropylpropafenone- / 5-Hydroxypropafenone
Matrix:
Human Plasma
LLOQ:
250
Unit:
pg/mL
Platform:Â
LC-MS/MS
Propoxyphene/Norpropoxyphene
Matrix:
Human Plasma
LLOQ:
1
Unit:
ng/mL
Platform:Â
LC-MS/MS
Pseudoephedrine
Matrix:
Human Plasma
LLOQ:
5
Unit:
ng/mL
Platform:Â
LC-MS/MS
Ribavirin
Matrix:
Human Plasma
LLOQ:
5
Unit:
ng/mL
Platform:Â
LC-MS/MS
Rifampin
Matrix:
Human DBS
LLOQ:
200
Unit:
ng/mL
Platform:Â
LC-MS/MS
Risperidone
Matrix:
Human Plasma
LLOQ:
0.1
Unit:
ng/mL
Platform:Â
LC-MS/MS
Ropinirole
Matrix:
Human Plasma
LLOQ:
20
Unit:
pg/mL
Platform:Â
LC-MS/MS
Ropinirole
Matrix:
Mini-Pig Plasma
LLOQ:
20
Unit:
pg/mL
Platform:Â
LC-MS/MS
Rosuvastatin
Matrix:
Human Plasma
LLOQ:
0.2
Unit:
ng/mL
Platform:Â
LC-MS/MS
Simvastatin / Simvastatin Hydroxy Acid
Matrix:
Human Plasma
LLOQ:
0.5 / 0.5
Unit:
ng/mL
Platform:Â
LC-MS/MS
Spironolactone
Matrix:
Human Plasma
LLOQ:
2
Unit:
ng/mL
Platform:Â
LC-MS/MS
Sumatriptan
Matrix:
Human Plasma
LLOQ:
0.5
Unit:
ng/mL
Platform:Â
LC-MS/MS
Tacrolimus
Matrix:
Human Whole Blood
LLOQ:
0.5
Unit:
ng/mL
Platform:Â
LC-MS/MS
Tacrolimus
Matrix:
Rat DBS
LLOQ:
5
Unit:
ng/mL
Platform:Â
LC-MS/MS
Tacrolimus
Matrix:
Dog Whole Blood
LLOQ:
0.1
Unit:
ng/mL
Platform:Â
LC-MS/MS
Temazepam
Matrix:
Human Plasma
LLOQ:
20
Unit:
ng/mL
Platform:Â
LC-MS/MS
Tenofovir
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:Â
LC-MS/MS
Terbinafine
Matrix:
Human Nail
LLOQ:
5
Unit:
pg/mg
Platform:Â
LC-MS/MS
Terbinafine / N-Desmethylterbinafine
Matrix:
Human Plasma
LLOQ:
40
Unit:
pg/mL
Platform:Â
LC-MS/MS
Tizanidine
Matrix:
Human Plasma
LLOQ:
100
Unit:
pg/mL
Platform:Â
LC-MS/MS
Tramadol
Matrix:
Dog Plasma
LLOQ:
2
Unit:
ng/mL
Platform:Â
LC-MS/MS
Tramadol / Acetaminophen
Matrix:
Human Plasma
LLOQ:
5 / 100
Unit:
ng/mL
Platform:Â
LC-MS/MS
Tretinoin / Isotretinoin
Matrix:
Human Plasma
LLOQ:
43383
Unit:
ng/mL
Platform:Â
LC-MS/MS
Triamcinolone
Matrix:
Human Plasma
LLOQ:
20
Unit:
pg/mL
Platform:Â
LC-MS/MS
Triamterene
Matrix:
Human Plasma
LLOQ:
2
Unit:
ng/mL
Platform:Â
LC-MS/MS
Tyramine
Matrix:
Human Plasma
LLOQ:
1
Unit:
ng/mL
Platform:Â
LC-MS/MS
Valproic Acid
Matrix:
Human Plasma
LLOQ:
0.5
Unit:
mcg/mL
Platform:Â
LC-MS/MS
Venlafaxine / O-Desmethylvenlafaxine
Matrix:
Human Plasma
LLOQ:
2.5
Unit:
ng/mL
Platform:Â
LC-MS/MS
Vitamin B6
Matrix:
Human Plasma
LLOQ:
50
Unit:
ng/mL
Platform:Â
LC-MS/MS
Zolmitriptan / N-Desmethylzolmitriptan
Matrix:
Human Plasma
LLOQ:
0.1 / 0.1
Unit:
ng/mL
Platform:Â
LC-MS/MS
Zolpidem
Matrix:
Human Plasma
LLOQ:
0.5
Unit:
ng/mL
Platform:Â
LC-MS/MS
First
Previous
1
2
3
4
Posts navigation
←
Previous Page
1
…
3
4
Search for:
Contact Us
KCAS Blog
Careers
Menu Toggle
Why a Career at KCAS
Roles We Hire
Menu Toggle
Scientist Jobs
Business Jobs
New Grads
How You’ll Benefit
Home
ABOUT
Menu Toggle
Why KCAS?
Leadership Team
Quality Assurance
Client Testimonials
SOLUTIONS
Menu Toggle
BIOMARKERS
Menu Toggle
Exploratory
Regulated CTA (Clinical Trial Application)
Non-Reg CTA (Clinical Trial Application)
MOLECULE TYPE
Menu Toggle
Small Molecule
Large Molecule
Cell & Gene Therapy
Other (Mixed-Mode Macro-Molecules)
RESEARCH PHASE
Menu Toggle
Early Research
Discovery
Pre-Clinical
Clinical Development
Manufacturing & Commercialization
Therapeutic Area
Menu Toggle
Autoimmune and Immunological
Cancer/Oncology
Cardiovascular & Metabolic
Gastrointestinal
Neurological Disorders
Ophthalmology
Orphan/Rare Diseases
Respiratory
Renal (kidney)
Infectious Diseases & Vaccines
Platforms
Menu Toggle
ELISA
ELISpot
Flow Cytometry
Hybrid LC-MS/MS
LC-MS/MS
Ligand Binding Assays
Meso Scale Discovery (ECL)
LC-UV/Fluorescence
Luminex
Quantitative PCR (qPCR and ddPCR)
IsoPlexis
News & Events
Menu Toggle
Upcoming Events
News
Resources
Menu Toggle
Compound Classes
Posters & White Papers
Info Sheets
Contact Us
KCAS Blog
Careers
Menu Toggle
Why a Career at KCAS
Roles We Hire
Menu Toggle
Scientist Jobs
Business Jobs
New Grads
How You’ll Benefit
Scroll to Top